The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2018 | Introducing the National Optimal Lung Cancer Pathway (NOLCP) in the UK

Name: Introducing the National Optimal Lung Cancer Pathway (NOLCP) in the UK
Uploaded: 2018-01-24T00:00:00Z
Duration: 53 s
Description: The National Optimal Lung Cancer Pathway (NOLCP) was a much-discussed topic at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland. Speaking from the meeting, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses the implementation of this pathway, including timelines, investment and infrastructure.

Neal Navani • 24 Jan 2018

BTOG 2018

Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

The National Optimal Lung Cancer Pathway (NOLCP) was a much-discussed topic at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland. Speaking from the meeting, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses the implementation of this pathway, including timelines, investment and infrastructure.